The bankrupt 23andMe, along with all of its genetic data, has been bought by US drugmaker Regeneron Pharmaceuticals.
This article has been indexed from Malwarebytes
The bankrupt 23andMe, along with all of its genetic data, has been bought by US drugmaker Regeneron Pharmaceuticals.